Search

Wondering how cryo-electron microscopy will impact medicine? Hear it from the source.

… Friday, September 9, 2016 Summary Memorial Sloan Kettering recently acquired a powerful new microscope that promises to greatly enhance scientists’ ability to understand the structure and function of biological molecules — including those that malfunction in cancer. In biology, structure and function

A single surviving myeloma cell can seed accelerated relapse, and more than 20 percent of nonsynonymous mutations at relapse may be induced by exposure to chemotherapy such as platinum and high-dose melphalan after autologous stem cell transplant.

… Friday, August 14, 2020 A single surviving myeloma cell can seed accelerated relapse, and more than 20 percent of nonsynonymous mutations at relapse may be induced by exposure to chemotherapy such as platinum and high-dose melphalan after autologous stem cell transplant, according to our research, published

Learn why an MSK patient is supporting the MSK mission with a bequest.

… Tuesday, November 7, 2023 Claire Theobald’s journey with breast cancer has taught her to cherish every small, beautiful moment of life. It has also inspired her to include Memorial Sloan Kettering Cancer Center (MSK) in her estate planning by making a bequest to MSK in her will. Her hope, she explains

Women with Stage III ovarian cancer when treated with a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, survived almost a year longer than those who received IV chemotherapy alone.

… Wednesday, January 4, 2006 According to a study published in the January 5 issue of the New England Journal of Medicine , women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median

An MSK expert gives advice on how to talk to family and friends about a cancer diagnosis linked to HPV, which some people find particularly challenging.

… Tuesday, May 3, 2022 Talking about a cancer diagnosis can be tough. Talking with friends, family, and others about a cancer diagnosis linked to HPV can be particularly challenging for many people. Memorial Sloan Kettering Cancer Center (MSK) clinical social worker Victoria Lassen has counseled people

Un experto de MSK ofrece consejos sobre cómo hablar con familiares y amigos sobre un diagnóstico de cáncer relacionado con el VPH, algo que para algunas personas puede resultar especialmente difícil.

… Tuesday, May 3, 2022 Hablar sobre un diagnóstico de cáncer puede ser difícil. Hablar con amigos, familiares y otras personas sobre un diagnóstico de cáncer relacionado con el VPH puede resultar especialmente difícil para muchas personas. Victoria Lassen , trabajadora social clínica del Memorial Sloan

Meet Vanessa Rodriguez, who is an event production manager in the Office of Development, where she works to enhance donor relationships to help fund cancer research.

… Wednesday, September 15, 2021 A common thread of purpose-driven work is woven through Vanessa Rodriguez’s professional life. She has worked for various nonprofit organizations throughout her career and will celebrate her 10th anniversary at Memorial Sloan Kettering Cancer Center in October. “My husband

MSK researchers identify mutations that convert nonthreatening thyroid tumors into aggressive cancers.

… Tuesday, August 8, 2017 Summary Most non-anaplastic thyroid cancers grow slowly and do not pose a threat. However, a small percentage become aggressive and spread quickly. Researchers have identified mutations that appear to turn these nonthreatening thyroid tumors into aggressive cancers. Highlights

Dr. Blinderman is a national leader in supportive care.

… Wednesday, November 1, 2023 Craig D. Blinderman, MD has been appointed Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Blinderman is a national leader in supportive care who comes to MSK from Columbia University Medical Center/NewYork-Presbyterian Hospital, where

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.

… Monday, February 19, 2024 By the summer of 2022, Roberto Romero was running out of options to treat the melanoma he’d been coping with since 2015. He’d already had several surgeries and many rounds of drug treatment. But the cancer — which started as a dark spot under a toenail — continued to grow and